ImmunoBee
📍мошенники сделали дубликат моего канала как закрытую группу. Будьте внимательны!!!!! Этот канал единственный!!! Immunology, PhD, учёный-иммунолог НЕ сотрудничаю, рекламы на канале НЕТ. ✅РКН: 5095931011
Show more📈 Analytical overview of Telegram channel ImmunoBee
Channel ImmunoBee (@immunobee1) in the Russian language segment is an active participant. Currently, the community unites 105 079 subscribers, ranking 100 in the Medicine category and 5 143 in the Russia region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 105 079 subscribers.
According to the latest data from 02 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -483 over the last 30 days and by 2 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 21.90%. Within the first 24 hours after publication, content typically collects 10.92% reactions from the total number of subscribers.
- Post reach: On average, each post receives 23 013 views. Within the first day, a publication typically gains 11 470 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 779.
- Thematic interests: Content is focused on key topics such as вич, орви, вакцина, доза, кишечник.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“📍мошенники сделали дубликат моего канала как закрытую группу. Будьте внимательны!!!!! Этот канал единственный!!!
Immunology, PhD, учёный-иммунолог
НЕ сотрудничаю, рекламы на канале НЕТ.
✅РКН: 5095931011”
Thanks to the high frequency of updates (latest data received on 03 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Available now! Telegram Research 2025 — the year's key insights 
